How Many Women With PCOS Are Infertile?

Roughly three out of four women with polycystic ovary syndrome report difficulty getting pregnant, according to a large community-based study that found infertility in 72% of women with PCOS compared with 16% of women without the condition.¹ That number sounds alarming, but it hides a crucial detail: “infertile” in medical terms means failing to conceive after a year of trying, not permanent inability to have children. When researchers followed PCOS patients long term, about 87% of those who attempted pregnancy eventually gave birth, and nearly three-quarters of those births came from spontaneous conception without any medical assistance.² The gap between the terrifying headline and the reassuring long-term picture is where the real story lives.

The Numbers in Context

PCOS is the most common hormonal disorder in women of reproductive age, and it is the leading cause of anovulatory infertility, meaning infertility caused by the ovaries not reliably releasing eggs.³ Globally, the number of infertility cases attributed to PCOS doubled between 1990 and 2019, reaching about 12 million.⁴ That rise reflects both growing PCOS prevalence and better diagnosis, not simply that PCOS has become harder to treat.

A population-based study from Denmark tracked the cumulative probability of childbirth after spontaneous conception. Among women with PCOS, about 55% eventually had a child from a natural pregnancy, compared with roughly 74% of women without the condition.⁵ That gap is real but far smaller than many women fear at the point of diagnosis. And when fertility treatments are factored in, the childbirth rate climbs higher still. The long-term follow-up study found that nearly 87% of PCOS patients who tried to conceive eventually had at least one child.²

So the honest answer is: PCOS makes it significantly harder to get pregnant, and the process often takes longer, but most women with the condition who want children ultimately have them. The 72% infertility figure from that community survey captures a moment in time (difficulty conceiving within the standard 12-month window), not a final outcome.¹

Why PCOS Disrupts Ovulation

The core fertility problem in PCOS is anovulation: the ovaries contain many small follicles but repeatedly fail to push one to full maturity and release an egg. The precise mechanism is still debated, but the current picture involves two reinforcing problems. First, excess androgens inside the ovary appear to stimulate too many small follicles to begin growing at once, creating a crowd of follicles in the 2-to-5-millimeter range.⁶ That crowd then jams the selection process. Normally, one follicle wins out and becomes dominant while the others fade. With too many competing follicles, the signals that would allow a single winner get diluted. Anti-Müllerian hormone, produced by the excess follicles, plays a role in blocking that selection step.

Second, insulin resistance amplifies the hormonal chaos. High insulin levels act on the ovary to ramp up androgen production and alter how luteinizing hormone (LH) works on follicle cells.⁷ Elevated LH, linked to the high insulin, further suppresses the follicle-stimulating hormone (FSH) that the ovary needs to push one follicle over the finish line.⁸ The result is a cycle that stalls month after month: follicles start but never finish, and no egg gets released.

PCOS Phenotypes and Why They Matter for Fertility

PCOS is not a single condition. Under the widely used Rotterdam criteria, a woman needs two of three features for a diagnosis: irregular or absent ovulation, excess androgens (clinical or lab-measured), and polycystic-appearing ovaries on ultrasound. Different combinations produce different phenotypes, and they do not all carry the same fertility burden.

About two-thirds of women evaluated in one series had the “frank” phenotype, meaning all three features were present.⁹ This group tends to have the highest body weight, the most insulin resistance, the worst menstrual irregularity, and the most resistance to first-line ovulation drugs.¹⁰ By contrast, women with the “ovulatory” phenotype (excess androgens plus polycystic ovaries, but who still ovulate) make up around 13% of diagnoses and often conceive without much trouble. The point is that a PCOS diagnosis alone tells you relatively little about a specific woman’s fertility prospects. The severity of anovulation and the metabolic profile matter far more than the label itself.

First-Line Fertility Treatments

For women with PCOS who are not ovulating, the first step in treatment is usually an oral medication to trigger ovulation. Letrozole has emerged as the preferred choice. In a large multicenter trial, women taking letrozole had a cumulative live birth rate of about 28%, compared with about 19% for those on clomiphene citrate, the older standard.¹¹ A systematic review confirmed the advantage, finding that letrozole increased the chance of a live birth by roughly 55% compared with clomiphene.¹² Smaller trials have reported even wider gaps, with one finding letrozole pregnancy rates around 29% versus 15% for clomiphene and live birth rates of 25% versus 11%.¹³

Metformin, the diabetes drug, also has a role, though a supporting one. It improves insulin sensitivity, lowers androgen levels, and can help restore regular cycles.¹⁴ Used alone, metformin improves ovulation rates compared with placebo but falls well short of letrozole or clomiphene for actually producing pregnancies and live births.¹⁵ Where metformin earns its place is in combination therapy. Adding metformin to clomiphene outperforms either drug alone and is particularly useful for women who don’t respond to clomiphene by itself.¹⁶

When Medications Are Not Enough

If oral medications fail, the next options are injectable hormones (gonadotropins) to stimulate the ovaries more aggressively, or a minor surgical procedure called laparoscopic ovarian drilling (LOD). LOD involves using a laser or cautery to make small holes in the ovarian surface, which reduces androgen-producing tissue and often restores ovulation for months to years afterward. Pregnancy and live birth rates with LOD are comparable to those seen with gonadotropin injections, without the elevated risk of twins or ovarian hyperstimulation.¹⁷ LOD is typically reserved for women who don’t respond to clomiphene or letrozole.¹⁸

If all else fails, IVF is the final rung on the treatment ladder, and IVF outcomes for women with PCOS are surprisingly comparable to those for women without the condition. A meta-analysis found that pregnancy and live birth rates per IVF cycle were similar between PCOS and non-PCOS women.¹⁹ One study reported live birth rates of 37% per cycle in women with PCOS versus 40% in women with normal ovaries, a statistically insignificant gap.²⁰

The catch is that PCOS ovaries overreact to the stimulating hormones used in IVF, which raises the risk of ovarian hyperstimulation syndrome (OHSS). OHSS can cause fluid buildup, pain, blood clots, and in rare cases can be life-threatening. The risk is roughly three to four times higher in women with PCOS than in those without.¹⁹ Severe OHSS occurred in about 15% of PCOS patients in one center, compared with under 3% for women with normal ovaries.²⁰ Modern IVF protocols have gotten better at managing this risk through lower stimulation doses, GnRH agonist triggers instead of hCG, and freeze-all strategies.²¹ Cycle cancellation rates also run higher for PCOS patients, primarily because clinicians halt cycles when the ovaries respond too aggressively.¹⁹

The AMH Paradox in IVF

Anti-Müllerian hormone (AMH) is commonly used as a marker of ovarian reserve, and higher levels generally predict a better response to IVF stimulation. But in women with PCOS, AMH levels tend to be elevated well beyond the normal range, and here the relationship flips. Among PCOS patients undergoing IVF, women with lower AMH levels actually had higher pregnancy rates, clinical pregnancy rates, and cumulative live birth rates than those with very high AMH.²² The likely explanation is that extremely high AMH reflects more severe follicular arrest and greater disruption of the selection mechanism. For PCOS patients considering IVF, very high AMH is not the good news it would be in the general population. It can signal a more treatment-resistant form of the condition.

Lifestyle Changes and Weight Loss

For women with PCOS who are overweight, lifestyle modification is consistently recommended as the first thing to try. A study of overweight women with anovulatory PCOS found that a program of diet and exercise, without aggressive calorie restriction, reduced central body fat, improved insulin sensitivity, and restored ovulation.²³ Even modest weight loss (around 5-10% of body weight) can restart ovulation in some women, because the drop in insulin levels breaks the hormonal feedback loop that keeps follicles from maturing.

A systematic review of exercise studies in women with PCOS or anovulatory infertility confirmed that physical activity, with or without dietary changes, can lead to ovulation resuming. The mechanism runs through the same pathway: lower insulin and free androgen levels, which allow the normal hormonal signals to reassert control.²⁴ This does not mean exercise alone is a fertility treatment. But for the substantial proportion of women with PCOS whose anovulation is driven primarily by insulin resistance and excess weight, it can make the difference between needing medication and not needing it.

Pregnancy Complications After Conceiving

Getting pregnant is only part of the challenge. Women with PCOS face higher rates of several pregnancy complications, including miscarriage, gestational diabetes, hypertensive disorders, and preterm delivery.²⁵ The miscarriage risk is elevated even in IVF settings where embryos are screened for chromosomal abnormalities, which suggests the problem is not just egg quality. One matched study found that lean PCOS patients had higher early miscarriage rates and lower live birth rates than non-PCOS controls even after transfer of chromosomally normal embryos, pointing to something in the uterine environment itself.²⁶

The risk of preeclampsia has been harder to pin down. A large national register study found that PCOS on its own modestly raised the odds, but the risk jumped substantially when gestational diabetes was also present.²⁷ A separate study, however, found no statistically significant link between PCOS and preeclampsia after adjusting for body weight and other factors.²⁸ The mixed evidence suggests that much of the preeclampsia risk attributed to PCOS is actually driven by the metabolic problems that accompany it, such as obesity and insulin resistance, rather than by PCOS per se. That distinction matters because it means addressing those metabolic factors can meaningfully lower the risk.

The Psychological Weight of a PCOS Diagnosis

One underappreciated consequence of being told you have PCOS is the anxiety it creates around fertility, sometimes years before a woman is ready to have children. A qualitative study found that the majority of women who received a PCOS diagnosis, regardless of how severe their symptoms were, experienced prolonged worry about infertility. Some took risks with contraception or rushed into trying to conceive earlier than planned, out of fear that waiting would mean missing their window entirely.²⁹ Given that the long-term data show most PCOS women eventually conceive, this fear often outpaces the reality. Better counseling at the time of diagnosis could spare many women years of unnecessary dread and the life-altering decisions it can drive.

Does PCOS Fertility Improve With Age?

Here is a genuinely surprising finding: some women with PCOS become more fertile as they get older, bucking the general trend of declining fertility with age. Clinical observations have documented women with PCOS who had failed years of fertility treatment in their twenties and then spontaneously conceived in their late thirties or early forties. One explanation is that as a woman ages, her total follicle count naturally declines, which means there are fewer follicles competing for dominance. With a smaller crowd, the normal FSH-driven selection process can finally work. FSH levels also tend to rise slightly with age, further helping to push a single follicle to full maturity.³⁰

This does not mean women with PCOS should plan to wait. Age-related egg quality decline still applies, and the risks of pregnancy complications rise with maternal age. But it does help explain why the long-term birth statistics look so much more optimistic than the initial diagnosis suggests. Some portion of those eventual pregnancies are the result of the condition naturally softening over time.

Why PCOS Has Persisted in the Population

A question that has puzzled evolutionary biologists: if PCOS reduces fertility, why hasn’t natural selection eliminated it? One hypothesis frames PCOS as a condition that, in pre-modern environments, conferred advantages that offset the fertility cost. These may have included greater physical sturdiness, more efficient energy storage (helpful when food was scarce), and hormonal profiles that benefited the survival of existing children and kin.³¹ Under this model, PCOS women in ancestral environments were not “infertile” in the way we define the term today. They had fewer children, spaced further apart, but those children may have survived at higher rates. In a feast-or-famine world, having a slightly lower fertility rate but better metabolic reserves could have been a net advantage. The mismatch between the PCOS metabolic profile and modern sedentary, calorie-rich environments may be what tips the balance from “slightly reduced fecundity” to “clinical infertility” for many women today.

Epigenetic Inheritance and Daughters

PCOS runs in families, but the genetics are complex and no single gene explains it. Emerging research points to epigenetic mechanisms, changes in how genes are switched on or off without altering the DNA sequence itself, as a way the condition passes between generations. The hormonal and metabolic environment inside the uterus of a woman with PCOS can modify gene expression in the developing fetus, potentially programming the next generation for PCOS-like traits.³² This means that a mother’s metabolic health during pregnancy may influence whether her daughter develops PCOS, independent of which genes she inherits. It also raises the possibility that improving the metabolic environment during pregnancy through managing insulin resistance and maintaining a healthy weight could reduce the severity of PCOS in the next generation, though that hypothesis is still being tested.

1
PubMed. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study
2
Human Reproduction. Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve
3
PubMed Central. Fertility Treatment Options for Women With Polycystic Ovary Syndrome
4
Human Reproduction. Global, regional, and national burden of infertility attributable to PCOS, 1990–2019
5
Human Reproduction. Fecundity among women with polycystic ovary syndrome (PCOS)—a population-based study
6
Human Reproduction Update. The follicular excess in polycystic ovaries, due to intra‐ovarian hyperandrogenism, may be the main culprit for the follicular arrest
7
Endocrine Reviews. Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
8
PubMed Central. An update of polycystic ovary syndrome: causes and therapeutics options
9
PubMed Central. Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome
10
PubMed Central. Comparison of the Different PCOS Phenotypes Based on Clinical Metabolic, and Hormonal Profile, and their Response to Clomiphene
11
PubMed Central. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome
12
PubMed. Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis
13
PubMed Central. Efficacy of Letrozole vs Clomiphene Citrate for induction of ovulation in women with polycystic ovarian syndrome
14
PubMed Central. Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
15
PubMed. Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline
16
PubMed Central. Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
17
PubMed Central. Laparoscopic ovarian drilling: An alternative but not the ultimate in the management of polycystic ovary syndrome
18
PubMed. Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome
19
PubMed. In vitro fertilization outcomes in women with polycystic ovary syndrome: A meta-analysis
20
PubMed. IVF outcome in women with PCOS, PCO and normal ovarian morphology
21
PubMed Central. Minimising OHSS in women with PCOS
22
PubMed Central. Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary Syndrome
23
The Journal of Clinical Endocrinology & Metabolism. Restoration of Reproductive Potential by Lifestyle Modification in Obese Polycystic Ovary Syndrome: Role of Insulin Sensitivity and Luteinizing Hormone
24
PubMed. Effect of Exercise on Ovulation: A Systematic Review
25
PubMed Central. Pregnancy in polycystic ovary syndrome
26
PubMed. Early miscarriage rate in lean polycystic ovary syndrome women after euploid embryo transfer – a matched-pair study
27
PubMed Central. Polycystic ovary syndrome and gestational diabetes mellitus association to pregnancy outcomes: A national register-based cohort study
28
PubMed Central. Polycystion ovary syndrome and the risk of preeclampsia
29
Human Reproduction Open. The benefits and harms of receiving a polycystic ovary syndrome diagnosis: a qualitative study of women’s experiences
30
PubMed. Ageing and reproduction: is polycystic ovary syndrome an exception?
31
PubMed Central. Polycystic ovary syndrome: an ancient disorder?
32
Reproduction. Mechanisms of intergenerational transmission of polycystic ovary syndrome